HY-13208-50mg
|
MedChemexpress LLC
|
Xevinapant (hydrochloride) [CAS 1071992-57-8]
|
|
Cancer-programmed cell death
|
|
HY-12758A-10mg
|
MedChemexpress LLC
|
YHO-13351 (free base) [CAS 912288-64-3]
|
|
Cancer-programmed cell death
|
|
HY-12758A-100mg
|
MedChemexpress LLC
|
YHO-13351 (free base) [CAS 912288-64-3]
|
|
Cancer-programmed cell death
|
|
HY-12758A-5mg
|
MedChemexpress LLC
|
YHO-13351 (free base) [CAS 912288-64-3]
|
|
Cancer-programmed cell death
|
|
HY-12758A-50mg
|
MedChemexpress LLC
|
YHO-13351 (free base) [CAS 912288-64-3]
|
|
Cancer-programmed cell death
|
|
HY-12758A-1mL
|
MedChemexpress LLC
|
YHO-13351 (free base) [CAS 912288-64-3] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-132300A-10mg
|
MedChemexpress LLC
|
ZW4864 (free base) [CAS 2632259-92-6]
|
|
Cancer-programmed cell death
|
|
HY-132300A-100mg
|
MedChemexpress LLC
|
ZW4864 (free base) [CAS 2632259-92-6]
|
|
Cancer-programmed cell death
|
|
HY-132300A-25mg
|
MedChemexpress LLC
|
ZW4864 (free base) [CAS 2632259-92-6]
|
|
Cancer-programmed cell death
|
|
HY-132300A-5mg
|
MedChemexpress LLC
|
ZW4864 (free base) [CAS 2632259-92-6]
|
|
Cancer-programmed cell death
|
|
HY-132300A-50mg
|
MedChemexpress LLC
|
ZW4864 (free base) [CAS 2632259-92-6]
|
|
Cancer-programmed cell death
|
|
HY-132300A-1mL
|
MedChemexpress LLC
|
ZW4864 (free base) [CAS 2632259-92-6] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|